Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Cell Death & Disease
|
April 15, 2016
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
D Carlisi, G Buttitta, R Di Fiore, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 14, 2007
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib
S Emanuele, M Lauricella, D Carlisi, et al.
International Journal of Oncology
|
October 16, 2013
Parthenolide induces superoxide anion production by stimulating EGF receptor in MDA-MB-231 breast cancer cells
A D'Anneo, D Carlisi, S Emanuele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL
S Emanuele, A D'Anneo, G Bellavia, et al.
Molecular Pharmacology
|
February 18, 2010
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis
O Pellerito, G Calvaruso, P Portanova, et al.
FEBS Letters
|
January 27, 2005
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells
A De Blasio, C Messina, A Santulli, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 11, 2006
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways
M Lauricella, S Emanuele, A D'Anneo, et al.
International Journal of Oncology
|
May 22, 2026
[Expression of Concern] Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects
D Carlisi, B Vassallo, M Lauricella, et al.
International Journal of Oncology
|
December 22, 2007
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects
D Carlisi, B Vassallo, M Lauricella, et al.
Cell Death & Disease
|
November 2, 2013
Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer
A D'Anneo, D Carlisi, M Lauricella, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Cell Death & Disease
|
April 15, 2016
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
D Carlisi, G Buttitta, R Di Fiore, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 14, 2007
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib
S Emanuele, M Lauricella, D Carlisi, et al.
International Journal of Oncology
|
October 16, 2013
Parthenolide induces superoxide anion production by stimulating EGF receptor in MDA-MB-231 breast cancer cells
A D'Anneo, D Carlisi, S Emanuele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL
S Emanuele, A D'Anneo, G Bellavia, et al.
Molecular Pharmacology
|
February 18, 2010
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis
O Pellerito, G Calvaruso, P Portanova, et al.
FEBS Letters
|
January 27, 2005
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells
A De Blasio, C Messina, A Santulli, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 11, 2006
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways
M Lauricella, S Emanuele, A D'Anneo, et al.
International Journal of Oncology
|
May 22, 2026
[Expression of Concern] Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects
D Carlisi, B Vassallo, M Lauricella, et al.
International Journal of Oncology
|
December 22, 2007
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects
D Carlisi, B Vassallo, M Lauricella, et al.
Cell Death & Disease
|
November 2, 2013
Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer
A D'Anneo, D Carlisi, M Lauricella, et al.
Page
of 5